Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
ANI Pharmaceuticals Inc. logo

ANI Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

61.32
 
USD
  
0.96
  
(1.59%)
Optionable: Yes  Market Cap: 1,301 M  90-day average vol: 160,873

Previous close: 60.36  Open: 60.18  Bid: 61.33  Ask: 77.5
52 week range    
44.27   
   70.81
Peers   
JAZZ / 
LCI / 
INFI / 
CLDX / 
EVOK / 
TEVA / 
RPRX / 
NVS / 
CAH / 
Last updated: Sunday 26th May 2024
42
MarketXLS Rank
60
Value
23
Technical
44
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

CAH

0.037314 B13.352.63

CLDX

1 B-17.331.4

EVOK

0 B-1.80.54

INFI

0 B-2.21.24

JAZZ

9 B-54.9141.13

LCI

0 B-0.20.9026

NVS

PFE

0.0302298 B15.153.21

RPRX

0.018917 B20.640.19

TEVA

Financials

ANIP Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AccruedPreferredStockDividends190000.0
Basic EPS from continuing operations2.611.340.34-0.091.310.51-1.88-3.4-3.050.86
Basic EPS total2.611.340.34-0.091.310.51-1.88-3.4-3.050.86
Basic weighted shares outstanding11 M11 M11 M12 M12 M12 M12 M13 M16 M18 M
Cost of sales11 M13 M49 M79 M73 M63 M87 M101 M139 M182 M
Depreciation47 M57 M60 M
Depreciation unreconciled4 M7 M22 M28 M34 M45 M45 M47 M57 M60 M
DepreciationAndAmortization4 M7 M22 M28 M34 M45 M45 M47 M57 M60 M
Diluted EPS total2.591.320.34-0.091.30.5-1.88-3.4-3.050.85
Diluted normalized net income/share2.591.320.34-0.091.30.5-1.88-3.4-3.050.85
Diluted weighted shares outstanding11 M12 M12 M12 M12 M12 M12 M13 M16 M18 M
Dividends paid per share7.6
Gross operating profit44 M64 M80 M98 M129 M143 M121 M116 M178 M305 M
ImpairmentOfCapitalAssets7 M903000.075000.0446000.02 M
Income before tax19 M22 M9 M16 M20 M3 M-26 M-56 M-64 M20 M
Income restructuring and M&A500000.06 M1 M
Income taxes-9 M6 M5 M17 M5 M-3 M-3 M-13 M15 M1 M
InterestExpenseNonOperating787000.011 M11 M12 M15 M13 M9 M12 M28 M27 M
MinorityInterests-2 M-2 M
MiscOtherSpecialCharges-12 M-4 M670000.0
Net income from total operations29 M15 M4 M-1 M15 M6 M-23 M-43 M-80 M17 M
NetIncomeCommonStockholders29 M15 M4 M-1 M15 M6 M-23 M-43 M-80 M17 M
NetIncomeContinuousOperations29 M15 M4 M-1 M15 M6 M-23 M-43 M-79 M19 M
NetNonOperatingInterestIncomeExpense787000.011 M11 M12 M15 M13 M9 M12 M-28 M-27 M
Normalized income10 M16 M13 M13 M15 M295000.0-29 M-58 M-41 M16 M
Operating income20 M33 M27 M29 M35 M16 M7 M-28 M-26 M49 M
Operating income before depreciation (EBITDA)24 M40 M42 M56 M69 M61 M28 M3 M24 M107 M
OperatingExpense24 M31 M53 M69 M93 M127 M114 M144 M204 M256 M
Other income net160000.041000.0-7 M-848000.0-550000.0-303000.0-940000.0-16 M4 M1 M
Other special charges9 M
OtherCostofRevenue139 M182 M
OtherImpairmentOfCapitalAssets446000.02 M112000.0
OtherOperatingExpenses7 M-11 M780000.0670000.0159000.0
OtherunderPreferredStockDividend190000.02 M
PreferredStockDividends190000.02 M
Research & development expense3 M3 M3 M9 M15 M20 M16 M11 M22 M34 M
ResearchExpense16 M11 M22 M34 M
RestructringAndMnAIncome500000.06 M1 M
Revenue per share45 M
Selling Gen & administrative expense18 M21 M28 M32 M44 M56 M65 M84 M124 M162 M
SellingAndMarketingExpense65 M84 M124 M162 M
Special income/charges7 M903000.075000.0446000.012 M-6 M-1 M
Total Income available for interest expense (EBIT)20 M33 M20 M28 M35 M16 M-17 M-44 M-36 M47 M
Total common shares outstanding11 M12 M12 M12 M12 M12 M12 M17 M13 M
Total net income29 M15 M4 M-1 M15 M6 M-23 M-43 M-80 M17 M
Total ordinary shares21 M21 M21 M21 M21 M21 M21 M21 M21 M21 M
Total revenues56 M76 M129 M177 M202 M207 M208 M216 M316 M487 M
TotalExpenses-36 M-44 M-102 M-148 M-166 M-190 M-202 M-244 M
TotalRevenue56 M76 M129 M177 M202 M207 M208 M216 M316 M487 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University